The TAXUS ATLAS Small Vessel and Long Lesion studies global

The TAXUS ATLAS Small Vessel and Long Lesion studies global, multicenter, historical studies, de novo lesions in 411 patients are controlled at 24 sites , the Small Vessel study was designed to evaluate the safety and efficacy of the TAXUS Libert ?? compared mm stent adapted for superiority in a case history matched bare metal stents control , and non-inferiority against a case historical control group of TAXUS Express stent patients. The Long lesion study was designed to? matched show that the TAXUS Libert Long Stent is non-inferior in safety and efficacy compared to a case of historical control group of TAXUS Express Stent and the TAXUS Express stent patients? .

Guided BASF Dr. Jens Rieger, Scientific Director of Polymer Research and Harvard, David Weitz, Mallinckrodt Professor of Physics and Applied Physics, and George Whitesides, Woodford L. And Ann A. Flowers University Professor, will the initiative. Rieger working with Weitz, a broad-based research network of faculty and students in laboratories throughout the Harvard is composed. Faculty investigators have the freedom to distribute and publish their findings from the research initiative effort.

Dr. Wakelin said: ‘What we have found that in the end is the balance of all the evidence in that enzymes in detergents does not demonstrating be a cause of the two cause skin irritation or skin allergies research from numerous persons to Dermatology ascribed Massage Products compelling that enzymes are non. In fact, were responsible enzyme-containing detergent extensive history of safe use Thus the alleged negative effects of enzymes on mythological be a consequence of mythology appear to ‘.